Keyword: Chris Viehbacher CEO
News
14.02.2011
- Genzyme Corp investors' confidence that the U.S. biotech is close to an agreement to be taken over by Sanofi-Aventis could be shaken if the French drugmaker extends its tender...
News
10.02.2011
- Sanofi Aventis Chief Executive Chris Viehbacher said in an interview that the French pharmaceuticals group's offer for Genzyme could be extended for a third time, beyond the Feb...
News
07.02.2011
- The boards of Sanofi-Aventis SA and Genzyme Corp were scheduled to hold separate meetings on Sunday to discuss a potential deal, but talks may linger into the week, sources...
